In contrast to cardiorenal syndrome ... should the enhancement of cardiovascular death initiated by kidney disease be termed 'renocardiac syndrome'? As the kidney is the primary regulator of ...

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...

Aims We sought to assess the prevalence and clinical correlates of cardiorenal anaemia (CRA) syndrome in systolic heart failure and the relationship between renal dysfunction and anaemia on hard ...

Here, the authors show that apelin offers potential cardiorenal protection for this high-risk patient group.

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ...

The National Women's Health Research Initiative (NWHRI), a joint initiative between the Canadian Institutes of Health Research and Women and Gender ...

Obesity is a widespread health issue influenced by genetic and lifestyle factors. This article explores its definition, ...

Tech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, ...

The Obesity Society (“TOS”), the leading professional society focused on obesity science, treatment, and prevention, is pleased to welcome Sherlyn Celone-Arnold, MS, as Chief of Strategy and ...

M.D., Ph.D., chief medical officer of BridgeBio's cardiorenal business, said in a Sept. 28 release. The results were meant to be presented at the Heart Failure Society of America’s annual ...

Ardelyx is a biopharmaceutical company focusing on gastrointestinal and cardiorenal treatments. Its product portfolio ...

October 2024 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of ...